Medigene Current Valuation vs. Profit Margin
| MDGEFDelisted Stock | USD 2.59 0.00 0.00% |
For Medigene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medigene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medigene AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medigene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medigene AG over time as well as its relative position and ranking within its peers.
Medigene |
Medigene AG Profit Margin vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medigene's current stock value. Our valuation model uses many indicators to compare Medigene value to that of its competitors to determine the firm's financial worth. Medigene AG is rated below average in current valuation category among its peers. It is considered to be number one stock in profit margin category among its peers . The ratio of Current Valuation to Profit Margin for Medigene AG is about 99,946,337 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medigene's earnings, one of the primary drivers of an investment's value.Medigene Current Valuation vs. Competition
Medigene AG is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is now estimated at about 4.63 Billion. Medigene maintains roughly 30.5 Million in current valuation contributing less than 1% to stocks in Biotechnology industry.
Medigene Profit Margin vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Medigene |
| = | 30.5 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Medigene |
| = | 0.31 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Medigene Profit Margin Comparison
Medigene is currently under evaluation in profit margin category among its peers.
Medigene Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Medigene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medigene will eventually generate negative long term returns. The profitability progress is the general direction of Medigene's change in net profit over the period of time. It can combine multiple indicators of Medigene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company was founded in 1994 and is headquartered in Munich, Germany. Medigene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 61 people.
Medigene Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medigene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medigene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medigene's important profitability drivers and their relationship over time.
Use Medigene in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medigene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigene will appreciate offsetting losses from the drop in the long position's value.Medigene Pair Trading
Medigene AG Pair Trading Analysis
The ability to find closely correlated positions to Medigene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigene AG to buy it.
The correlation of Medigene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medigene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medigene AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medigene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Medigene position
In addition to having Medigene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Office Supplies Thematic Idea Now
Office Supplies
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Medigene Pink Sheet
If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |